Filing Details

Accession Number:
0001209191-16-129868
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-06-28 15:17:39
Reporting Period:
2016-06-24
Filing Date:
2016-06-28
Accepted Time:
2016-06-28 15:17:39
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1117480 Chimerix Inc CMRX Pharmaceutical Preparations (2834) 330903395
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1180469 Ernest Mario C/O Chimerix, Inc.
2505 Meridian Parkway, Suite 100
Durham NC 27713
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-06-24 50,000 $3.70 381,440 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Acquisiton 2016-06-24 9,000 $0.00 9,000 $3.73
Common Stock Stock Option (Right to Buy) Acquisiton 2016-06-24 9,634 $0.00 9,634 $3.73
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
9,000 2026-06-23 No 4 A Direct
9,634 2026-06-23 No 4 A Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.6399 to $3.70, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information will be provided regarding the number of shares purchased or sold at each separate price.
  2. The shares subject to the option vest in a series of 12 equal monthly installments from the date of grant; provided, however, that the option shall become fully vested on the date that is the earlier of (i) the one-year anniversary of the date of grant and (ii) the date of the Company's 2017 annual stockholder meeting.